Vaccine Induction of Heterologous HIV-1 Neutralizing Antibody B Cell Lineages in Humans

Author:

Williams Wilton B.,Alam S. Munir,Ofek Gilad,Erdmann Nathaniel,Montefiori David,Seaman Michael S.,Wagh Kshitij,Korber Bette,Edwards Robert J.,Mansouri Katayoun,Eaton Amanda,Cain Derek W.,Martin Mitchell,Parks Robert,Barr Maggie,Foulger Andrew,Anasti Kara,Patel Parth,Sammour Salam,Parsons Ruth J.,Huang Xiao,Lindenberger Jared,Fetics Susan,Janowska Katarzyna,Niyongabo Aurelie,Janus Benjamin M.,Astavans Anagh,Fox Christopher B.,Mohanty Ipsita,Evangelous Tyler,Chen Yue,Berry Madison,Kirshner Helene,Van Itallie Elizabeth,Saunders Kevin,Wiehe Kevin,Cohen Kristen W.,McElrath M. Juliana,Corey Lawrence,Acharya Priyamvada,Walsh Stephen R.,Baden Lindsey R.,Haynes Barton F.

Abstract

SummaryA critical roadblock to HIV vaccine development is the inability to induce B cell lineages of broadly neutralizing antibodies (bnAbs) in humans. In people living with HIV-1, bnAbs take years to develop. The HVTN 133 clinical trial studied a peptide/liposome immunogen targeting B cell lineages of HIV-1 envelope membrane proximal external region (MPER) bnAbs (NCT03934541). Here, we report MPER peptide-liposome induction of polyclonal HIV-1 B cell lineages of mature bnAbs and their precursors, the most potent of which neutralized 15% of global tier 2 HIV-1 strains and 35% of clade B strains, with lineage initiation after the second immunization. Neutralization was enhanced by vaccine-selection of improbable mutations that increased antibody binding to gp41 and lipids. This study demonstrates proof-of-concept for rapid vaccine induction of human B cell lineages with heterologous neutralizing activity and selection of antibody improbable mutations, and outlines a path for successful HIV-1 vaccine development.

Publisher

Cold Spring Harbor Laboratory

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3